S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Section

Market Quotes

Found 8918 articles

Market Quotes

IDB Sees AI Lifting Latin American GDP by Up to 5.1%

Broad adoption of artificial intelligence could raise Latin America and the Caribbean’s GDP by as much as 5.1% over 10 years, while wages could climb 4.2%, the Inter-American Development Bank said in a report. The gains depend on governments and businesses putting the policies, infrastructure and skills in place to support adoption.

Market Quotes

Lennox’s $21–$21.50 EPS Guidance Is Adjusted

Lennox Industries’ full-year earnings-per-share guidance of $21 to $21.50 is for adjusted EPS, not GAAP EPS, the company said. A headline published at 6:45 a.m. ET on Oct. 28 incorrectly described the guidance as GAAP.

Market Quotes

Oil Futures Drop as Surplus Fears Outweigh Middle East Risks

Oil prices fell in midday trading Monday as forecasts of a global supply surplus weighed on futures, despite continued attacks and threats to shipping in the Middle East. January ICE Brent was down $2.51 at $93.33 a barrel by noon, while December WTI had fallen $2.19 to $86.37.

Market Quotes

Clearwater Paper Shares Jump 12% After Price and Executive Updates

Clearwater Paper shares climbed 12% to $16.23 on Monday after the company said most customers outside RISI-indexed business had received its second price increase of the year and announced two executive appointments. The stock remains down 6.7% year to date.

Market Quotes

Stronger Dollar Pressures Grain and Sugar Prices

The U.S. dollar’s rise to 19-month highs is setting a difficult backdrop for dollar-priced commodities, while traders also weigh Federal Reserve signals, U.S.-China talks and crop conditions. Grain prices could face further pressure if policymakers point to interest rates staying higher for longer, Peak Trading Research analysts said.

Market Quotes

NHTSA Probes 1.03 Million Honda Odysseys Over Engine Restart Complaints

The National Highway Traffic Safety Administration has opened an engineering analysis into an automatic engine stop feature in 2024–2026 Honda Odysseys after receiving 701 complaints that some engines failed to restart when drivers released the brake pedal.

Market Quotes

Iambic Therapeutics Shares Drop 11% After Wider Quarterly Loss

Iambic Therapeutics shares fell 11% to $11.60 on Monday after the company reported a wider third-quarter loss and collaboration revenue below analysts’ expectations. The life-sciences and technology company made its public debut last month, selling nearly 9.38 million shares at $16 apiece.

Market Quotes

Nvidia Releases Chemistry Dataset and AI Training Recipes

Nvidia has introduced Nemotron for Science, an open chemistry dataset and a set of post-training recipes intended to help researchers build AI agents for scientific discovery. The platform is designed to let agents reason through scientific problems and use specialized research tools, the company said Monday.

Market Quotes

U.S. Corn and Soybean Inspections Ease as Wheat Rises

U.S. export inspections of corn and soybeans fell in the week ended Nov. 12, while wheat inspections increased, according to the U.S. Department of Agriculture’s latest report. Year-to-date figures diverged: corn and wheat trailed last year’s pace, but soybeans remained ahead.

Market Quotes

Toyo Shares Slide as Profit and Revenue Decline

Toyo shares fell 5.2% to $4.40 on Monday after the Tokyo-based solar manufacturer reported lower quarterly profit and revenue. The company reaffirmed its guidance but said it was taking a cautious approach amid changing trade policies and proceedings involving its Ethiopia facility.

Market Quotes

Northrop Grumman Wins $1.6 Billion Army Rocket-Motor Pact

A $1.6 billion Northrop Grumman agreement will expand production of solid rocket motors and key components for the U.S. Army’s Missile Segment Enhancement program, supporting Lockheed Martin’s production of PAC-3 MSE interceptors.

Market Quotes

Aclaris Shares Fall 8.7% After Bosakitug Trial Misses Endpoints

Aclaris Therapeutics shares fell 8.7% to $3.58 shortly after Monday’s opening bell after the company reported that bosakitug failed to meet the primary and secondary endpoints in a Phase 2 trial for moderate-to-severe atopic dermatitis.

Market Quotes

Arcturus Shares Gain 10% After Meiji’s $50 Million Investment

Arcturus Therapeutics shares climbed 10% to $9.23 in Monday morning trading after the RNA medicine company announced an expanded collaboration with Meiji Seika Pharma that includes a $50 million equity investment priced at an 80% premium to the market price.

Market Quotes

CG Oncology Shares Jump 20% on Bladder Cancer Trial Results

A 68% reduction in recurrence risk in a Phase 3 trial sent CG Oncology shares sharply higher Monday, after the company said its bladder cancer treatment met the study’s primary endpoint. The stock rose 20% to $89.30, and has more than doubled year to date.

Market Quotes

Lexeo Shares Rise 24% on Interim LX2020 Trial Results

Lexeo Therapeutics shares rose 24% to $3.55 in premarket trading Monday after the company reported interim results from a trial of LX2020, its treatment for PKP2 arrhythmogenic cardiomyopathy. The gain came after the stock had fallen 71% this year through Friday’s close.

Market Quotes

Outdoor Holding’s Quarterly Profit More Than Doubles

Outdoor Holding’s fiscal second-quarter net income attributable to common stockholders rose to $1.53 million from about $656,000 a year earlier, while revenue increased to $13.7 million. The company said firearm sales and gross merchandise value also grew from the prior-year quarter.

Market Quotes

Cadre Holdings CFO Blaine Browers to Leave at Year-End

Cadre Holdings CFO Blaine Browers will leave the company at the end of the year to become finance chief at a diversified, large-cap manufacturer of engineered critical components, the company said. Chad Appleby, Cadre’s vice president and treasurer since 2014, will serve as interim CFO.

Market Quotes

Aramark’s Quarterly Profit Rises as Revenue Gains 4.8%

Aramark’s fiscal fourth-quarter profit rose to $137.9 million as revenue increased 4.8% to $5.29 billion, with the food-services and facilities-management company citing new business and improved customer retention. Adjusted earnings, however, came in below analysts’ expectations.

Market Quotes

Alpha Tau Shares Rise 13% on Glioblastoma Trial Results

All six evaluable patients in Alpha Tau Medical’s study of its Alpha DaRT therapy for recurrent glioblastoma had an objective response, the company said. Five had no measurable tumor remaining at the treated site, while the sixth had a 58% reduction in tumor measurements.

Market Quotes

Church & Dwight to Buy 45% of Bali Treatment for $225 Million

Church & Dwight will pay $225 million for a 45% stake in Bali Treatment, a European hair care and styling company whose brands are expanding beyond Germany and Austria. The household and personal care products maker said the investment is intended to support international growth through consumer brands that require relatively few assets.

Market Quotes

Medtronic to Acquire Contego Medical for $380 Million

Medtronic has agreed to acquire privately held Contego Medical for $380 million, adding carotid artery and peripheral thrombectomy technologies to its portfolio. The deal includes Contego’s recently FDA-approved Neuroguard IEP direct system, which combines transcarotid artery revascularization with embolic protection and flow reversal.

Market Quotes

XPeng Posts Third Straight Quarterly Loss, Forecasts Q4 Sales Jump

XPeng expects vehicle deliveries to rise as much as 50% in the final quarter of 2026, even as the Chinese electric-vehicle maker reported a larger loss for the third quarter and missed analysts’ expectations. The forecast points to a renewed push for a strong year-end finish.

Market Quotes

Summit Therapeutics Falls 18% After FDA Rejects Ivonescimab Application

Summit Therapeutics shares fell 18% to $11.59 in premarket trading Monday after the FDA declined to approve the company’s ivonescimab application for certain patients with advanced lung cancer. The decision followed the agency’s finding that evidence was insufficient to show the treatment extended patients’ lives.

Market Quotes

Clearwater Paper Names Matt Passarello CFO

Clearwater Paper has appointed Matt Passarello chief financial officer, elevating an executive who joined the Spokane, Washington-based paperboard packaging products supplier in April 2024.

Market Quotes

Canadian Natural to Acquire Advantage Energy for C$2.255 Billion

Canadian Natural Resources has agreed to buy Calgary-based Advantage Energy for about C$2.255 billion (US$1.56 billion), adding production and development acreage in western Canada. The transaction’s total value is about C$2.53 billion when Advantage’s debt and convertible debentures are included.

Market Quotes

Uniper Targets Higher Earnings as European Power Demand Grows

Uniper expects adjusted EBITDA to rise to between 1.2 billion euros and 1.5 billion euros in 2027, up from a forecast range of 1.1 billion euros to 1.3 billion euros for 2026. The German utility said growing European power consumption and resilient gas demand are supporting its outlook.

Market Quotes

Henry Schein Cuts EPS Guidance to Exclude Remeasurement Gains

Henry Schein lowered its full-year adjusted earnings-per-share forecast after deciding to exclude certain acquisition-related remeasurement gains from its adjusted results. The company now expects adjusted EPS of $5.42 to $5.48, down from its previous range of $5.50 to $5.56.

Market Quotes

Intel shareholders sue over alleged disclosure failures

Intel shareholders are seeking damages after the company’s stock fell 28.6% in one day, alleging it failed to disclose how a slump in PC sales and an inventory glut were affecting its business. The proposed class action was filed Friday by Robbins LLP, a U.S. shareholder rights law firm.

Market Quotes

Mahanadi Coalfields Seeks $9.55 Billion Valuation in IPO

Mahanadi Coalfields has set a price band of 129 to 136 rupees a share for an IPO that could raise as much as 90.01 billion rupees, or $954.8 million, according to a notice on the company’s website. The offering would value the Coal India subsidiary at up to $9.55 billion after the sale.